Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD098, AD153, and AD639 for obstructive sleep apnoea
ACTRN12618001499279Phase 2Completed
- Sponsor
- Apnimed, Inc.
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of AD098 and AD109 in obstructive sleep apnea hypopnea syndrome (OSAHS) (4 arms), sponsored by Apnimed, Inc. Primary endpoint: Apnoea/hypopnoea index. Started Feb 2019; status: completed.
02
Drugs
AD098AD109
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12618001499279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001499279.